Combination treatment with nivolumab and Rigvir of a progressive stage IIC skin melanoma patient

Abstract

A 35-year-old male patient was diagnosed with stage IIC skin melanoma that rapidly progressed after surgery. Treatment was continued with radiotherapy, which did not stop further spread of disease and the patient was put on a combination of nivolumab and Rigvir. Subsequently, the progression has slowed.

Description

Publisher Copyright: © 2019 Rigvir. Clinical Case Reports Published by John Wiley & Sons Ltd.

Keywords

combination treatment, metastatic melanoma, nivolumab, oncolytic virus, Rigvir, 3.2 Clinical medicine, 1.1. Scientific article indexed in Web of Science and/or Scopus database, General Medicine

Citation

Brokāne, L, Jaunalksne, I, Tilgase, A, Olmane, E, Petroška, D, Rasa, A & Alberts, P 2019, 'Combination treatment with nivolumab and Rigvir of a progressive stage IIC skin melanoma patient', Clinical Case Reports, vol. 7, no. 6, pp. 1191-1196. https://doi.org/10.1002/ccr3.2182